Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53

Oncogene

Volumn 24, Issue 55, 2005, Pages 8176-8186

  Seo, Junghee ^a,b   Chung, Yun S ^a   Sharma, Girdhar G ^c   Moon, Eunpyo ^b   Burack, Walter R ^a   Pandita, Tej K ^c   Choi, Kyunghee ^a,d  

^a School of Medicine   (United States)

^b Ajou University   (South Korea)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Cancer; Cdt1; Genomic instability; p53

Indexed keywords

CELL CYCLE PROTEIN 6; CHROMOSOME PROTEIN; DNA; MINI CHROMOSOME MAINTANANCE PROTEIN; PROTEIN; PROTEIN P53; REPLICATION LICENSING FACTOR CDT1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL MATURATION; CELL STRAIN 3T3; CHROMOSOME TRANSLOCATION; DOUBLE MINUTE CHROMOSOME; FEMALE; GENE OVEREXPRESSION; GENOMIC INSTABILITY; LYMPHOBLASTOMA; MALE; MOUSE; NONHUMAN; NUMERICAL CHROMOSOME ABERRATION; PLOIDY; PRIORITY JOURNAL; ROBERTSONIAN CHROMOSOME TRANSLOCATION; STRUCTURAL CHROMOSOME ABERRATION; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE; TUMOR CELL;

ANIMALIA; EUKARYOTA; MUS MUSCULUS; ROBERTSONIA;

EID: 28744444389     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208881     Document Type: Article

References (46)

1. Arentson E, Faloon P, Seo J, Moon E, Studts JM, Fremont DH and Choi K. (2002). Oncogene, 21, 1150-1158.
2. Bell SP and Stillman B. (1992). Nature, 357, 128-134.
3. Bergers G, Javaherian K, Lo KM, Folkman J and Hanahan D. (1999). Science, 284, 808-812.
4. Blow JJ and Tada S. (2000). Nature, 404, 560-561.
5. Bonds L, Baker P, Gup C and Shroyer KR. (2002). Arch. Pathol. Lab. Med., 126, 1163-1168.
6. Bouck N, Stellmach V and Hsu SC. (1996). Adv. Cancer Res., 69, 135-174.
7. Chaffin KE, Beals CR, Wilkie TM, Forbush KA, Simon MI and Perlmutter RM. (1990). EMBO J., 9, 3821-3829.
8. Dhar S, Squire JA, Hande MP, Wellinger RJ and Pandita TK. (2000). Mol. Cell. Biol., 20, 7764-7772.
9. Donehower LA. (1996). Semin. Cancer Biol., 7, 269-278.
10. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM and Dryja TP. (1986). Nature, 323, 643-646.
11. Fujita M. (1999). Front. Biosci., 4, D816-D823.
12. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
13. Hall M and Peters G. (1996). Adv. Cancer Res., 68, 67-108.
14. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
15. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
16. Hartwell LH. (1976). J. Mol. Biol., 104, 803-817.
17. Hirama T and Koeffler HP. (1995). Blood, 86, 841-854.
18. Hofmann JF and Beach D. (1994). EMBO J., 13, 425-434.
19. Hunt CR, Dix DJ, Sharma GG, Pandita RK, Gupta A, Funk M and Pandita TK. (2004). Mol. Cell. Biol., 24, 899-911.
20. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
21. Knudson Jr AG. (1971). Proc. Natl. Acad. Sci. USA, 68, 820-823.
22. Maine GT, Sinha P and Tye BK. (1984). Genetics, 106, 365-385.
23. Maiorano D, Moreau J and Mechali M. (2000). Nature, 404, 622-625.
24. Melixetian M, Ballabeni A, Masiero L, Gasparini P, Zamponi R, Bartek J, Lukas J and Helin K. (2004). J. Cell Biol., 165, 473-482.
25. Moir D, Stewart SE, Osmond BC and Botstein D. (1982). Genetics, 100, 547-563.
26. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A. (1991). Nature, 350, 512-515.
27. Nishitani H, Lygerou Z, Nishimoto T and Nurse P. (2000). Nature, 404, 625-628.
28. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
29. Ohta S, Koide M, Tokuyama T, Yokota N, Nishizawa S and Namba H. (2001). Oncol. Rep., 8, 1063-1066.
30. Quintana DG and Dutta A. (1999). Front. Biosci., 4, D805-D815.
31. Saxena S and Dutta A. (2003). Cell Cycle, 2, 283-286.
32. Sherr CJ. (1996). Science, 274, 1672-1677.
33. Shreeram S and Blow JJ. (2003). Prog. Cell Cycle Res., 5, 287-293.
34. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
35. Tada S, Li A, Maiorano D, Mechali M and Blow J. (2001). Nat. Cell. Biol., 3, 107-113.
36. Tan DF, Huberman J, Hyland A, Loewen G, Brooks J, Beck A, Todorov I and Bepler G. (2001). BMC Cancer, 1, 6.
37. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.
38. Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y, Wagle N, Hwang DS and Dutta A. (2003). Mol. Cell, 11, 997-1008.
39. Wharton SB, Hibberd S, Eward KL, Crimmins D, Jellinek DA, Levy D, Stoeber K and Williams GH. (2004). Br. J. Cancer, 91, 262-269.
40. Whittaker AJ, Royzman I and Orr-Weaver TL. (2000). Genes Dev., 14, 1765-1776.
41. Wildin RS, Garvin AM, Pawar S, Lewis DB, Abraham KM, Forbush KA, Ziegler SF, Allen JM and Perlmutter RM. (1991). J. Exp. Med., 173, 383-393.
42. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC and Dutta A. (2000). Science, 290, 2309-2312.
43. Wohlschlegel JA, Kutok JL, Weng AP and Dutta A. (2002). Am. J. Pathol., 161, 267-273.
44. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse P and Taraviras S. (2004). Eur. J. Biochem., 271, 3368-3378.
45. Yarden Y and Ullrich A. (1988). Annu. Rev. Biochem., 57, 443-478.
46. Zhu W, Chen Y and Dutta A. (2004). Mol. Cell. Biol., 24, 7140-7150.